Cargando…
In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection
BACKGROUND: Toll-like receptors (TLRs), Coronin-1 and Sp110 are essential factors for the containment of Mycobacterium tuberculosis infection. The purpose of this study was to investigate the in vivo expression of these molecules at different stages of the infection and uncover possible relationship...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931512/ https://www.ncbi.nlm.nih.gov/pubmed/20718957 http://dx.doi.org/10.1186/1471-2334-10-243 |
_version_ | 1782186054702333952 |
---|---|
author | Constantoulakis, Pantelis Filiou, Eftihia Rovina, Nikoletta Chras, George Hamhougia, Aggeliki Karabela, Simona Sotiriou, Adamandia Roussos, Charis Poulakis, Nikolaos |
author_facet | Constantoulakis, Pantelis Filiou, Eftihia Rovina, Nikoletta Chras, George Hamhougia, Aggeliki Karabela, Simona Sotiriou, Adamandia Roussos, Charis Poulakis, Nikolaos |
author_sort | Constantoulakis, Pantelis |
collection | PubMed |
description | BACKGROUND: Toll-like receptors (TLRs), Coronin-1 and Sp110 are essential factors for the containment of Mycobacterium tuberculosis infection. The purpose of this study was to investigate the in vivo expression of these molecules at different stages of the infection and uncover possible relationships between these markers and the state of the disease. METHODS: Twenty-two patients with active tuberculosis, 15 close contacts of subjects with latent disease, 17 close contacts of subjects negative for mycobacterium antigens and 10 healthy, unrelated to patients, subjects were studied. Quantitative mRNA expression of Coronin-1, Sp110, TLRs-1,-2,-4 and -6 was analysed in total blood cells vs an endogenous house-keeping gene. RESULTS: The mRNA expression of Coronin-1, Sp110 and TLR-2 was significantly higher in patients with active tuberculosis and subjects with latent disease compared to the uninfected ones. Positive linear correlation for the expression of those factors was only found in the infected populations. CONCLUSIONS: Our results suggest that the up-regulation of Coronin-1 and Sp110, through a pathway that also includes TLR-2 up-regulation may be involved in the process of tuberculous infection in humans. However, further studies are needed, in order to elucidate whether the selective upregulation of these factors in the infected patients could serve as a specific molecular marker of tuberculosis. |
format | Text |
id | pubmed-2931512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29315122010-09-02 In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection Constantoulakis, Pantelis Filiou, Eftihia Rovina, Nikoletta Chras, George Hamhougia, Aggeliki Karabela, Simona Sotiriou, Adamandia Roussos, Charis Poulakis, Nikolaos BMC Infect Dis Research Article BACKGROUND: Toll-like receptors (TLRs), Coronin-1 and Sp110 are essential factors for the containment of Mycobacterium tuberculosis infection. The purpose of this study was to investigate the in vivo expression of these molecules at different stages of the infection and uncover possible relationships between these markers and the state of the disease. METHODS: Twenty-two patients with active tuberculosis, 15 close contacts of subjects with latent disease, 17 close contacts of subjects negative for mycobacterium antigens and 10 healthy, unrelated to patients, subjects were studied. Quantitative mRNA expression of Coronin-1, Sp110, TLRs-1,-2,-4 and -6 was analysed in total blood cells vs an endogenous house-keeping gene. RESULTS: The mRNA expression of Coronin-1, Sp110 and TLR-2 was significantly higher in patients with active tuberculosis and subjects with latent disease compared to the uninfected ones. Positive linear correlation for the expression of those factors was only found in the infected populations. CONCLUSIONS: Our results suggest that the up-regulation of Coronin-1 and Sp110, through a pathway that also includes TLR-2 up-regulation may be involved in the process of tuberculous infection in humans. However, further studies are needed, in order to elucidate whether the selective upregulation of these factors in the infected patients could serve as a specific molecular marker of tuberculosis. BioMed Central 2010-08-18 /pmc/articles/PMC2931512/ /pubmed/20718957 http://dx.doi.org/10.1186/1471-2334-10-243 Text en Copyright ©2010 Constantoulakis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Constantoulakis, Pantelis Filiou, Eftihia Rovina, Nikoletta Chras, George Hamhougia, Aggeliki Karabela, Simona Sotiriou, Adamandia Roussos, Charis Poulakis, Nikolaos In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
title | In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
title_full | In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
title_fullStr | In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
title_full_unstemmed | In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
title_short | In vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
title_sort | in vivo expression of innate immunity markers in patients with mycobacterium tuberculosis infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931512/ https://www.ncbi.nlm.nih.gov/pubmed/20718957 http://dx.doi.org/10.1186/1471-2334-10-243 |
work_keys_str_mv | AT constantoulakispantelis invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT filioueftihia invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT rovinanikoletta invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT chrasgeorge invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT hamhougiaaggeliki invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT karabelasimona invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT sotiriouadamandia invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT roussoscharis invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection AT poulakisnikolaos invivoexpressionofinnateimmunitymarkersinpatientswithmycobacteriumtuberculosisinfection |